Document Detail


Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.
MedLine Citation:
PMID:  23348905     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Scirrhous hepatocellular carcinoma is a rare ill-defined morphological subtype of hepatocellular carcinoma characterized by marked stromal fibrosis. This variant can be difficult to distinguish from intrahepatic cholangiocarcinoma and metastatic adenocarcinoma, especially on needle biopsies. We performed immunohistochemistry for hepatocellular and adenocarcinoma-associated markers on 20 scirrhous hepatocellular carcinoma cases and compared the results with classical hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Scirrhous hepatocellular carcinomas were significantly less likely to be HepPar-1 positive than classical hepatocellular carcinomas (26% and 74%, respectively; P<0.001) and were significantly more likely to express adenocarcinoma-associated markers such as epithelial cell adhesion molecule (63 vs 11%; P<0.001), cytokeratin 19 (26 vs 2%; P<0.001), and cytokeratin 7 (53 vs 2%; P<0.001). At least one of these adenocarcinoma-related markers was positive in 80% of scirrhous hepatocellular carcinoma cases. Glypican 3 and arginase were positive in 79% and 85% of cases of scirrhous hepatocellular carcinoma, respectively; the combined use of these two markers yielded 100% sensitivity for scirrhous hepatocellular carcinoma. In conclusion, the scirrhous morphology, absence of HepPar-1 staining, and frequent positivity with adenocarcinoma-related markers in scirrhous hepatocellular carcinoma can lead to an erroneous diagnosis of adenocarcinoma. Glypican 3 and arginase are the most reliable markers for identifying hepatocellular differentiation in this setting.Modern Pathology advance online publication, 25 January 2013; doi:10.1038/modpathol.2012.243.
Authors:
Gregor Krings; Rageshree Ramachandran; Dhanpat Jain; Tsung-Teh Wu; Matthew M Yeh; Michael Torbenson; Sanjay Kakar
Related Documents :
11091565 - Cystic hypersecretory duct carcinoma of the breast:a case reprot describing the cytolog...
8322705 - Comparison of nuclear grade and dna cytometry in breast carcinoma aspirates to histolog...
8057655 - Triple approach in the diagnosis of dominant breast masses: combined physical examinati...
17331275 - The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dyspla...
21860765 - Prostate cancer can be detected even in patients with decreased psa less than 2.5 ng/ml...
11964045 - Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-25
Journal Detail:
Title:  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc     Volume:  -     ISSN:  1530-0285     ISO Abbreviation:  Mod. Pathol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806605     Medline TA:  Mod Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular...
Next Document:  FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.